We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$10.9B
AUM Growth
+$1.47B
Cap. Flow
+$1.54B
Cap. Flow %
14.16%
Top 10 Hldgs %
12.66%
Holding
527
New
158
Increased
123
Reduced
88
Closed
149

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$163M
2
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$132M
3
AGN
Allergan plc
AGN
+$129M
4
DVN icon
Devon Energy
DVN
+$117M
5
EA
Electronic Arts
EA
+$115M

Top Sells

Rank Stock Value
1
PCP
PRECISION CASTPARTS CORP
PCP
+$93.6M
2
BRCM
BROADCOM CORP CL-A
BRCM
+$89.6M
3
XRX icon
Xerox
XRX
+$87.3M
4
ZTS icon
Zoetis
ZTS
+$82M
5
CFG icon
Citizens Financial Group
CFG
+$75.4M

Sector Composition

Rank Sector Weight
1 Technology 16.1%
2 Healthcare 14.81%
3 Industrials 13.15%
4 Financials 12%
5 Consumer Discretionary 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LHO
301
DELISTED
LaSalle Hotel Properties
LHO
$3.42M 0.03%
+135,257
New +$3.21M
AIV
302
Aimco
AIV
$383M
$3.38M 0.03%
+605,882
New +$3.1M
GNRT
303
DELISTED
Gener8 Maritime, Inc.
GNRT
$3.31M 0.03%
468,826
+14,492
+3% +$93.5K
OMED
304
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$3.29M 0.03%
325,000
+165,802
+104% +$1.95M
CTRE icon
305
CareTrust REIT
CTRE
$9.74B
$3.17M 0.03%
+250,000
New +$2.77M
IVR icon
306
Invesco Mortgage Capital
IVR
$805M
$3.11M 0.03%
+25,509
New +$2.95M
MHFI
307
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$3.03M 0.03%
30,652
-42,630
-58% -$3.82M
RTX icon
308
RTX Corp
RTX
$301B
$2.92M 0.03%
+46,267
New +$2.68M
TSE
309
DELISTED
Trinseo
TSE
$2.83M 0.03%
+76,975
New +$2.19M
FCE.A
310
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$2.7M 0.02%
+128,226
New +$2.52M
CRVS icon
311
Corvus Pharmaceuticals
CRVS
$1.17B
$2.64M 0.02%
+182,328
New +$2.62M
FNF icon
312
Fidelity National Financial
FNF
$13.5B
$2.64M 0.02%
+112,125
New +$2.51M
SAGE
313
DELISTED
Sage Therapeutics
SAGE
$2.53M 0.02%
+78,917
New +$2.78M
VTAE
314
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$2.49M 0.02%
+375,000
New +$3.41M
DAN icon
315
Dana Inc
DAN
$3.06B
$2.4M 0.02%
+170,087
New +$2.13M
R icon
316
Ryder
R
$10.1B
$2.38M 0.02%
+36,746
New +$2.09M
SNDX icon
317
Syndax Pharmaceuticals
SNDX
$1.82B
$2.33M 0.02%
+175,000
New +$2.2M
ARCC icon
318
Ares Capital
ARCC
$14.4B
$2.32M 0.02%
+156,131
New +$2.15M
BXP icon
319
Boston Properties
BXP
$11.1B
$2.26M 0.02%
+17,818
New +$2.11M
WCC
320
WESCO International
WCC
$17.7B
$2.22M 0.02%
+40,604
New +$1.8M
AXDX
321
DELISTED
Accelerate Diagnostics
AXDX
$2.21M 0.02%
15,399
+2,899
+23% +$409K
RXII
322
CALL
DELISTED
GALENA BIOPHARMA INC COM
RXII
$2.17M 0.02%
1,593,277
– –
HLT icon
323
Hilton Worldwide
HLT
$71.5B
$2.17M 0.02%
+32,067
New +$1.91M
EIGI
324
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$2.11M 0.02%
200,000
– –
VRSK icon
325
Verisk Analytics
VRSK
$25B
$2.03M 0.02%
+25,393
New +$1.85M
11 12
13
14 15

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q1 2016 Portfolio in Review

As of Q1 2016, Alyeska Investment Group held 527 positions worth $10.9B, up 16% from $9.41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Alyeska Investment Group deployed $1.54B of net new capital in Q1 2016, opening 158 new positions and adding to 123 existing holdings. Its largest new stake was Bausch Health: 2,200,000 shares worth $57.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Amdocs, an estimated $66.8M trimmed.

  • Alyeska Investment Group's largest Q1 2016 buy was Bausch Health: 2,200,000 shares worth $57.9M.
  • Alyeska Investment Group added most to Devon Energy in Q1 2016, an estimated $117M increase.
  • Alyeska Investment Group's biggest Q1 2016 reduction was Amdocs, cutting an estimated $66.8M.
  • Alyeska Investment Group fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $93.6M.
  • Alyeska Investment Group's ten largest holdings make up 13% of its $10.9B portfolio in Q1 2016.
  • Alyeska Investment Group opened 158 new positions and closed 149 in Q1 2016.
  • Alyeska Investment Group's portfolio value rose 16% quarter-over-quarter to $10.9B.

Based on Alyeska Investment Group's 13F filing for Q1 2016, filed 16 May 2016.